vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and Revolve Group, Inc. (RVLV). Click either name above to swap in a different company.
Revolve Group, Inc. is the larger business by last-quarter revenue ($324.4M vs $185.2M, roughly 1.8× AMICUS THERAPEUTICS, INC.). Revolve Group, Inc. runs the higher net margin — 5.7% vs 0.9%, a 4.8% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 10.4%). AMICUS THERAPEUTICS, INC. produced more free cash flow last quarter ($16.0M vs $-13.3M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 9.5%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
Revolve Theatre Company is a Henley-on-Thames based theatre company specialising in political and Shakespearean plays. The company is owned by Oliver Dench, Joe Morris and Tom Smith.
FOLD vs RVLV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $324.4M |
| Net Profit | $1.7M | $18.6M |
| Gross Margin | 85.7% | 53.3% |
| Operating Margin | 8.6% | 6.3% |
| Net Margin | 0.9% | 5.7% |
| Revenue YoY | 23.7% | 10.4% |
| Net Profit YoY | -88.5% | 50.4% |
| EPS (diluted) | $0.00 | $0.27 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $185.2M | $324.4M | ||
| Q3 25 | $169.1M | $295.6M | ||
| Q2 25 | $154.7M | $309.0M | ||
| Q1 25 | $125.2M | $296.7M | ||
| Q4 24 | $149.7M | $293.7M | ||
| Q3 24 | $141.5M | $283.1M | ||
| Q2 24 | $126.7M | $282.5M | ||
| Q1 24 | $110.4M | $270.6M |
| Q4 25 | $1.7M | $18.6M | ||
| Q3 25 | $17.3M | $21.2M | ||
| Q2 25 | $-24.4M | $10.2M | ||
| Q1 25 | $-21.7M | $11.8M | ||
| Q4 24 | $14.7M | $12.3M | ||
| Q3 24 | $-6.7M | $11.0M | ||
| Q2 24 | $-15.7M | $15.4M | ||
| Q1 24 | $-48.4M | $10.9M |
| Q4 25 | 85.7% | 53.3% | ||
| Q3 25 | 88.5% | 54.6% | ||
| Q2 25 | 90.2% | 54.1% | ||
| Q1 25 | 90.7% | 52.0% | ||
| Q4 24 | 90.1% | 52.5% | ||
| Q3 24 | 90.6% | 51.2% | ||
| Q2 24 | 91.1% | 54.0% | ||
| Q1 24 | 87.7% | 52.3% |
| Q4 25 | 8.6% | 6.3% | ||
| Q3 25 | 20.3% | 7.1% | ||
| Q2 25 | -6.1% | 5.8% | ||
| Q1 25 | -6.3% | 5.0% | ||
| Q4 24 | 10.7% | 3.9% | ||
| Q3 24 | 15.3% | 5.0% | ||
| Q2 24 | 11.8% | 5.8% | ||
| Q1 24 | -25.1% | 3.4% |
| Q4 25 | 0.9% | 5.7% | ||
| Q3 25 | 10.2% | 7.2% | ||
| Q2 25 | -15.8% | 3.3% | ||
| Q1 25 | -17.3% | 4.0% | ||
| Q4 24 | 9.8% | 4.2% | ||
| Q3 24 | -4.8% | 3.9% | ||
| Q2 24 | -12.4% | 5.4% | ||
| Q1 24 | -43.9% | 4.0% |
| Q4 25 | $0.00 | $0.27 | ||
| Q3 25 | $0.06 | $0.29 | ||
| Q2 25 | $-0.08 | $0.14 | ||
| Q1 25 | $-0.07 | $0.16 | ||
| Q4 24 | $0.05 | $0.18 | ||
| Q3 24 | $-0.02 | $0.15 | ||
| Q2 24 | $-0.05 | $0.21 | ||
| Q1 24 | $-0.16 | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $292.3M |
| Total DebtLower is stronger | $392.7M | — |
| Stockholders' EquityBook value | $274.2M | $512.5M |
| Total Assets | $949.9M | $765.0M |
| Debt / EquityLower = less leverage | 1.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $293.5M | $292.3M | ||
| Q3 25 | $263.8M | $315.4M | ||
| Q2 25 | $231.0M | $310.7M | ||
| Q1 25 | $250.6M | $300.8M | ||
| Q4 24 | $249.9M | $256.6M | ||
| Q3 24 | $249.8M | $252.8M | ||
| Q2 24 | $260.1M | $244.7M | ||
| Q1 24 | $239.6M | $273.4M |
| Q4 25 | $392.7M | — | ||
| Q3 25 | $392.0M | — | ||
| Q2 25 | $391.3M | — | ||
| Q1 25 | $390.7M | — | ||
| Q4 24 | $390.1M | — | ||
| Q3 24 | $389.5M | — | ||
| Q2 24 | $388.9M | — | ||
| Q1 24 | $388.4M | — |
| Q4 25 | $274.2M | $512.5M | ||
| Q3 25 | $230.4M | $490.2M | ||
| Q2 25 | $204.3M | $468.6M | ||
| Q1 25 | $193.6M | $453.4M | ||
| Q4 24 | $194.0M | $437.8M | ||
| Q3 24 | $178.8M | $420.8M | ||
| Q2 24 | $132.5M | $405.8M | ||
| Q1 24 | $130.7M | $389.9M |
| Q4 25 | $949.9M | $765.0M | ||
| Q3 25 | $868.8M | $751.3M | ||
| Q2 25 | $815.3M | $722.9M | ||
| Q1 25 | $789.8M | $713.9M | ||
| Q4 24 | $785.0M | $665.5M | ||
| Q3 24 | $786.6M | $670.9M | ||
| Q2 24 | $749.5M | $657.8M | ||
| Q1 24 | $721.8M | $650.0M |
| Q4 25 | 1.43× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.92× | — | ||
| Q1 25 | 2.02× | — | ||
| Q4 24 | 2.01× | — | ||
| Q3 24 | 2.18× | — | ||
| Q2 24 | 2.93× | — | ||
| Q1 24 | 2.97× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | $-10.2M |
| Free Cash FlowOCF − Capex | $16.0M | $-13.3M |
| FCF MarginFCF / Revenue | 8.6% | -4.1% |
| Capex IntensityCapex / Revenue | 0.2% | 1.0% |
| Cash ConversionOCF / Net Profit | 9.62× | -0.55× |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | $48.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.3M | $-10.2M | ||
| Q3 25 | $35.7M | $11.8M | ||
| Q2 25 | $-26.5M | $12.6M | ||
| Q1 25 | $7.8M | $45.1M | ||
| Q4 24 | $-3.9M | $3.9M | ||
| Q3 24 | $-23.0M | $9.1M | ||
| Q2 24 | $22.7M | $-24.7M | ||
| Q1 24 | $-29.7M | $38.4M |
| Q4 25 | $16.0M | $-13.3M | ||
| Q3 25 | $35.3M | $7.5M | ||
| Q2 25 | $-28.9M | $10.4M | ||
| Q1 25 | $7.5M | $43.4M | ||
| Q4 24 | $-4.2M | $2.1M | ||
| Q3 24 | $-23.3M | $8.0M | ||
| Q2 24 | $21.6M | $-25.7M | ||
| Q1 24 | $-31.5M | $36.7M |
| Q4 25 | 8.6% | -4.1% | ||
| Q3 25 | 20.9% | 2.5% | ||
| Q2 25 | -18.7% | 3.4% | ||
| Q1 25 | 6.0% | 14.6% | ||
| Q4 24 | -2.8% | 0.7% | ||
| Q3 24 | -16.5% | 2.8% | ||
| Q2 24 | 17.0% | -9.1% | ||
| Q1 24 | -28.5% | 13.5% |
| Q4 25 | 0.2% | 1.0% | ||
| Q3 25 | 0.2% | 1.5% | ||
| Q2 25 | 1.6% | 0.7% | ||
| Q1 25 | 0.2% | 0.6% | ||
| Q4 24 | 0.2% | 0.6% | ||
| Q3 24 | 0.3% | 0.4% | ||
| Q2 24 | 0.9% | 0.4% | ||
| Q1 24 | 1.6% | 0.6% |
| Q4 25 | 9.62× | -0.55× | ||
| Q3 25 | 2.06× | 0.56× | ||
| Q2 25 | — | 1.24× | ||
| Q1 25 | — | 3.82× | ||
| Q4 24 | -0.27× | 0.32× | ||
| Q3 24 | — | 0.83× | ||
| Q2 24 | — | -1.60× | ||
| Q1 24 | — | 3.53× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
RVLV
| Fashion Apparel | $155.1M | 48% |
| Dresses | $76.4M | 24% |
| Handbags Shoes And Accessories | $67.6M | 21% |
| Beauty | $20.3M | 6% |
| Manufactured Product Other | $5.0M | 2% |
| Breakage On Store Credit And Gift Cards | $900.0K | 0% |
